SCHEMBL9190606

SCHEMBL9190606

Cc1nc2cc(C(c3ccccc3)n3ccnc3)ccc2[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 4/20 0.53
CYP19A1 P11511 8/20 0.52
FNTA P49354 1/20 0.51
FNTB P49356 1/20 0.51
CNR1 P21554 4/20 0.50
CYP17A1 P05093 2/20 0.50
MEN1 O00255 1/20 0.50
NR1I2 O75469 1/20 0.50
USP2 O75604 1/20 0.50
ABCB11 O95342 1/20 0.50
ALDH1A1 P00352 1/20 0.50
PLA2G1B P04054 1/20 0.50
TP53 P04637 1/20 0.50
PGR P06401 1/20 0.50
HSP90AA1 P07900 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
IDO1 P14902 1/20 0.50
HPGD P15428 1/20 0.50
MAOA P21397 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669025 0.90 CYP19A1 (0.58) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL9198108 0.90 CYP19A1 (0.60) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL668660 0.89 CYP19A1 (0.59) CYP26A1CYP19A1FNTAFNTBCNR1
Irtemazole SCHEMBL7453697 0.86 CYP26A1 (0.57) CYP26A1CYP19A1FNTAFNTBCNR1
Irtemazole SCHEMBL9717354 0.86 CYP26A1 (0.57) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL669277 0.86 CYP19A1 (0.52) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL12337074 0.83 CYP19A1 (0.48) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL9663750 0.82 CYP26A1 (0.55) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL9663498 0.82 CYP26A1 (0.57) CYP26A1CYP19A1FNTAFNTBCNR1
SCHEMBL1626417 0.82 CYP19A1 (0.55) CYP26A1CYP19A1FNTAFNTBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed